LKB1 is classified as a tumor suppressor because loss of function mutations in LKB1 give rise to the Peutz-Jeghers syndrome, which is associated with benign gastrointestinal hamartomas and an elevated risk of developing carcinomas, including lung adenocarcinomas [22]. Here, STK11 is linked to Peutz-Jeghers syndrome.